NA Leber Congenital Amaurosis Market - Industry Trends and Forecast to 2029

North America leber congential amaurosis market is projected to register a CAGR of 4.4% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029
 

Market Segmentation: 
North America Leber Congenital Amaurosis Market, By Disease (Infantile Type, Juvenile Type and Other), Type (Therapy and Diagnosis), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the North America leber congential amaurosis market are:

• Rising prevalence of leber congenital amaurosis in children.
 

• Increasing healthcare expenditure

Market Players:

The key market players for North America leber congential amaurosis market are listed below:

• Invitae Corporation.
• Johnson & Johnson Services, Inc.
• Spark Therapeutics, Inc.
• LKC TECHNOLOGIES, INC.
• Amarantus Bioscience Holdings, Inc.
• Sucampo Pharmaceuticals, Inc.
• Orphagen Pharmaceuticals, Inc.